Question follow-through · 27813

Pancreatic Enzyme Replacement Therapy

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 January 2025 to Question 20760 on Pancreatic Enzyme Replacement Therapy, whether he has had recent discussions with Cabinet colleagues on increasing access to the raw in

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
30 Jan 2025
Target answer date
3 Feb 2025
Answer
5 Feb 2025 · 6 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 30 Jan 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 January 2025 to Question 20760 on Pancreatic Enzyme Replacement Therapy, whether he has had recent discussions with Cabinet colleagues on increasing access to the raw in

  2. 3 Feb 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 5 Feb 2025

    Answer published

    There have been no recent discussions with Cabinet Office colleagues on increasing the United Kingdom’s manufacturing capacity of pancreatic enzyme replacement therapy (PERT) or increasing access to the raw ingredients required for the production of PERT....

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Childbirth

1 Apr 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure NHS Trusts implement interventions set out in (a) the guidance entitled Saving Babies’ Lives Version Two: A care bundle for reducing perinatal mortalit

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Baby Care Units

1 Apr 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the (a) availability and (b) quality of overnight accommodation for parents in neonatal units.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Childbirth

1 Apr 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to expand access to (a) neonatal outreach services and (b) specialist perinatal mental health support for families of preterm babies following hospital discharge

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Childbirth

1 Apr 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve training for (a) health visitors and (b) community healthcare professionals on the needs of (i) preterm babies and (ii) their families.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Childbirth

1 Apr 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the rates at which children born preterm receive follow-up health and developmental assessments at ages (a) two and (b) four.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Childbirth

1 Apr 2025 · To ask the Secretary of State for Health and Social Care, whether he has made representations to the Secretary of State for Science, Innovation and Technology to encourage increased funding for research into preterm birth (a) prevention, b) treatment and

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Asthma: Birmingham Perry Barr

24 Jun 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help support people with asthma in Birmingham Perry Barr constituency.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Asthma: Medical Equipment

24 Jun 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of mandating the installation of dosage counters in all NHS-provided emergency asthma inhalers.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Asthma: Medical Equipment

24 Jun 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential benefits of amending the Human Medicines (Amendment) (No. 2) Regulations 2014 to require (a) colleges, (b) nurseries, and (c) universi

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Asthma: Medical Equipment

24 Jun 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of making all NHS-provided emergency asthma inhalers free of charge.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Asthma: Medical Equipment

4 Jul 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 3 July 2025 to Question 62444 on Asthma: Medical Equipment, what steps his Department is taking to encourage an increase in the number of market authorisation holders for

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Asthma: Medical Equipment

4 Jul 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 3 July 2025 to Question 62444 on Asthma: Medical Equipment, what recent discussions his Department has had with pharmaceutical companies on encouraging them to become mark